SecSonar.com

Pfizer Inc. (PFE)

Pfizer Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pfizer Inc. (PFE) is a Drug Manufacturers - General company based in US with a market capitalization of $148.6B. Revenue declined 1.6% year-over-year and the company generated $9.1B in free cash flow. This page tracks PFE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 81K employees · IPO Jun 1, 1972

Valuation

Valuation & price

$25.75 · as of May 13, 2026 · -9.8% vs 52w high

18.8

P/E ratio

Latest-FY diluted EPS

1.72

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$28.32$25.80$23.29Jul 25Dec 25Jul 26Jul 7, 25$25.24Jul 9, 25$25.56Jul 11, 25$25.65Jul 15, 25$24.61Jul 17, 25$24.58Jul 21, 25$24.26Jul 23, 25$25.36Jul 25, 25$24.79Jul 29, 25$24.30Jul 31, 25$23.29Aug 4, 25$23.53Aug 6, 25$23.93Aug 11, 25$24.58Aug 13, 25$25.16Aug 15, 25$25.14Aug 19, 25$25.32Aug 21, 25$25.74Aug 25, 25$25.14Aug 27, 25$25.07Aug 29, 25$24.76Sep 3, 25$24.79Sep 5, 25$24.88Sep 9, 25$24.71Sep 11, 25$24.86Sep 16, 25$23.90Sep 18, 25$24.15Sep 22, 25$24.04Sep 24, 25$24.09Sep 26, 25$23.76Sep 30, 25$25.48Oct 2, 25$27.08Oct 6, 25$26.43Oct 8, 25$25.68Oct 10, 25$24.78Oct 14, 25$24.52Oct 16, 25$24.23Oct 21, 25$24.85Oct 23, 25$24.67Oct 27, 25$24.77Oct 29, 25$24.29Oct 31, 25$24.65Nov 4, 25$24.30Nov 6, 25$24.85Nov 10, 25$24.39Nov 12, 25$25.87Nov 14, 25$25.06Nov 18, 25$25.45Nov 20, 25$24.40Nov 25, 25$25.72Nov 28, 25$25.74Dec 2, 25$25.15Dec 4, 25$25.70Dec 8, 25$25.77Dec 10, 25$25.78Dec 12, 25$25.85Dec 16, 25$25.53Dec 18, 25$25.04Dec 22, 25$25.21Dec 24, 25$25.03Dec 29, 25$25.00Jan 2, 26$25.18Jan 6, 26$25.43Jan 8, 26$25.29Jan 12, 26$25.27Jan 14, 26$25.58Jan 16, 26$25.65Jan 21, 26$25.89Jan 23, 26$25.65Jan 27, 26$26.50Jan 29, 26$26.10Feb 2, 26$26.66Feb 4, 26$26.78Feb 9, 26$27.05Feb 11, 26$27.73Feb 13, 26$27.58Feb 18, 26$27.37Feb 20, 26$26.65Feb 24, 26$27.14Feb 26, 26$27.10Mar 2, 26$27.26Mar 4, 26$26.62Mar 6, 26$27.05Mar 10, 26$27.16Mar 12, 26$26.86Mar 17, 26$27.45Mar 19, 26$27.41Mar 23, 26$26.77Mar 25, 26$27.28Mar 27, 26$27.04Mar 31, 26$28.08Apr 2, 26$28.32Apr 7, 26$27.10Apr 9, 26$27.22Apr 13, 26$27.34Apr 15, 26$27.19Apr 17, 26$27.56Apr 22, 26$26.80Apr 24, 26$27.00Apr 28, 26$26.48Apr 30, 26$26.70May 4, 26$26.30May 6, 26$26.53May 8, 26$25.68May 12, 26$25.87May 14, 26$25.75May 18, 26$25.33May 20, 26$25.79May 22, 26$25.90May 28, 26$26.14Jun 1, 26$25.63Jun 3, 26$25.34Jun 5, 26$26.04Jun 9, 26$25.70Jun 11, 26$26.17Jun 15, 26$26.00Jun 17, 26$25.92Jun 22, 26$25.08Jun 24, 26$24.04Jun 26, 26$24.29Jul 2, 26$24.32
$23.2952-week range$28.55
Loading valuation history…

Fundamentals

Key fundamentals

$148.6B

Market cap

-1.6%

Revenue growth (YoY)

70.3%

Gross margin

$9.1B

Free cash flow (USD)

$53.8B

Net debt

0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$52.8BFY 2017$52.5BFY 2018$53.6BFY 2019$41.2BFY 2020$41.7BFY 2021$81.3BFY 2022$100.3BFY 2023$59.6BFY 2024$63.6BFY 2025$62.6B
$52.8B$62.6B

Free cash flow by year

2016 → 2025

FY 2016$13.9BFY 2017$14.3BFY 2018$13.6BFY 2019$10.0BFY 2020$11.6BFY 2021$29.9BFY 2022$26.0BFY 2023$4.8BFY 2024$9.8BFY 2025$9.1B
$13.9B$9.1B

Gross margin by year

2021 → 2025

FY 202157.7%FY 202261.9%FY 202351.0%FY 202465.8%FY 202570.3%
57.7%70.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCFO TransitionJun 18, 2026Filing
  • 8-K eventFiscal Guidance ReaffirmedJun 18, 2026Filing
  • Insider sellInsider Sell $51KDAMICO JENNIFER B. · SVP & Controller · $51.4KJun 10, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 27, 2026Filing

Questions

Frequently asked questions

What is Pfizer Inc.'s market cap?

Pfizer Inc. (PFE) has a market capitalization of $148.6B.

What is PFE's P/E ratio?

PFE trades at a price-to-earnings ratio of 18.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PFE's price-to-book (P/B) ratio?

PFE trades at 1.72 times book value per share.

Are insiders buying PFE stock?

SEC Form 4 filings show no open-market insider buys at Pfizer Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - General

GILD

Gilead Sciences, Inc.

$167.4B

AMGN

Amgen Inc.

$180.9B

SNY

Sanofi

$105.6B

GSK

GSK plc

$101.9B

ZTS

Zoetis Inc.

$32.6B

BIIB

Biogen Inc.

$29.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.